EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND study

Torsten Kucharzik iD, Ulf Helwig iD, Frank Seibold iD, Luc Biedermann iD, Christoph Högenauer iD, Imma Fischer iD, Leonie Hammer iD, Stefan Rath iD, Christian Maaser iD, IBD DACH study group

Inflammatory Bowel Diseases · 01.09.2026 · 32 (9) · 1770-1782

DOI: 10.1093/ibd/izag074 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 19.05.2026. Verfasst von Torsten Kucharzik und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Gastroenterology, University Teaching Hospital Lüneburg, Lüneburg, Germany. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Intestines, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AbbVie, Inc, AbbVie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The study sought to prospectively examine clinical, biochemical, and transmural outcomes. Transmural outcomes are assessed by ultrasound after 1 year in patients with inflammatory bowel disease (IBD) treated in line with standard of care.

Methods

The TRUST BEYOND study is a prospective, multicenter, noninterventional study at 49 sites in Germany, Austria, and Switzerland and includes 282 patients with IBD who have active disease at baseline. For this analysis, 163 patients with IBD (74 with Crohn’s disease, 89 with ulcerative colitis) were followed up for 1 year. At baseline and at every 3 months, clinical, biochemical, and ultrasound parameters, such as bowel wall thickness and color Doppler sonography, were assessed.

Results

Patients with IBD demonstrated vast improvements in clinical, biochemical, and ultrasound assessments as early as week 12. Rates of transmural response and healing progressively increased over the study period to up to 77.5% and 39.3%, respectively, in patients with ulcerative colitis and to 66.2% and 27.0%, respectively, in patients with Crohn’s disease. Patients with early transmural response achieved numerically higher rates of various outcomes at week 52 than patients without early transmural response. In a multivariate analysis, transmural response at week 12 predicted clinical remission at week 52 (odds ratio, 4.3; 95% confidence interval, 2.45-7.52; P < .001).

Conclusions

These results suggest that intestinal ultrasound is a suitable noninvasive modality to monitor patients with IBD in routine care. Transmural endpoints can be achieved in patients with IBD treated with standard of care and can predict outcomes after 1 year.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeCrohn DiseaseIntestinesInflammatory Bowel DiseasesHumansFemaleMaleProspective StudiesRemission InductionAdultPrognosisFollow-Up StudiesMiddle AgedUltrasonography, Doppler, ColorUltrasonographyPredictive Value of Tests

Stichwörter der Autor:innen

inflammatory bowel diseasespredictorsultrasound

Autor:innen und Institutionen

  • Department of Internal Medicine and Gastroenterology, University Teaching Hospital Lüneburg, Lüneburg, Germany.
  • Gastroenterology Practice, Oldenburg, Germany.
  • University of Kiel, Kiel, Germany.
  • Crohn Colitis Centre, Bern, Switzerland.
  • University Clinic Zurich, Zurich, Switzerland.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

ORCID-Profile: Torsten Kucharzik, Ulf Helwig, Frank Seibold, Luc Biedermann, Christoph Högenauer, Imma Fischer, Leonie Hammer, Stefan Rath, Christian Maaser

Förderung

  • AbbVie, Inc
  • AbbVie

Zitieren

APA

Kucharzik, T., Helwig, U., Seibold, F., Biedermann, L., Högenauer, C., Fischer, I., Hammer, L., Rath, S., Maaser, C., & IBD DACH study group (2026). Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND study. Inflammatory Bowel Diseases, 32(9), 1770-1782. https://doi.org/10.1093/ibd/izag074

Vancouver

Kucharzik T, Helwig U, Seibold F, Biedermann L, Högenauer C, Fischer I, et al. Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND study. Inflammatory Bowel Diseases. 2026;32(9):1770-1782. doi:10.1093/ibd/izag074

BibTeX
@article{Kucharzik2026,
  author = {Kucharzik, Torsten and Helwig, Ulf and Seibold, Frank and Biedermann, Luc and Högenauer, Christoph and Fischer, Imma and Hammer, Leonie and Rath, Stefan and Maaser, Christian and IBD DACH study group, IBD DACH study group},
  title = {Early transmural response assessed by intestinal ultrasound predicts long-term clinical remission in patients with IBD: Results from the TRUST BEYOND study},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  volume = {32},
  number = {9},
  pages = {1770--1782},
  doi = {10.1093/ibd/izag074}
}
Kostenlos starten →